MAGE-A3 Recombinant Protein Is a Well Tolerated New Treatment for Lung Cancer: Presented at EMCTO
May 6th, 2009
LUGANO, Switzerland — May 6, 2009 — Melanoma antigen family A3 — also known as MAGE-A3 — recombinant protein is well tolerated in patients with non-small-cell lung cancer (NSCLC) and is clinically effective, according to research presented at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO) 2009.